SCHEMBL13724842

SCHEMBL13724842

Cc1ccc(-n2c3ccccc3c3cc(N(c4ccc(-c5ccc(N(c6ccc7c(c6)c6ccccc6n7-c6ccc(C)cc6)c6cccc7ccccc67)c6ccccc56)cc4)c4cccc5ccccc45)ccc32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 1/20 0.35
▸ KDM4E B2RXH2 4/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ CRHR1 P34998 1/20 0.32
▸ AKR1C4 P17516 1/20 0.32
▸ AKR1C3 P42330 1/20 0.32
▸ AKR1C2 P52895 1/20 0.32
▸ AKR1C1 Q04828 1/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ TP53 P04637 2/20 0.31
▸ ATM Q13315 1/20 0.31
▸ ALDH1A1 P00352 3/20 0.31
▸ HPGD P15428 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ MAPT P10636 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ EGFR P00533 1/20 0.31
▸ ERBB2 P04626 1/20 0.31
▸ PTGER4 P35408 1/20 0.31
▸ MCL1 Q07820 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13485940 0.97 KDM4E (0.36) FLT3KDM4ECRHR1AKR1C4AKR1C3
SCHEMBL13486055 0.97 KDM4E (0.36) FLT3KDM4ECRHR1AKR1C4AKR1C3
SCHEMBL13724531 0.97 FLT3 (0.36) FLT3KDM4EKMT2ACRHR1AKR1C4
SCHEMBL13486022 0.96 KDM4E (0.37) FLT3KDM4ECRHR1AKR1C4AKR1C3
SCHEMBL13485859 0.95 KDM4E (0.36) FLT3KDM4ECRHR1AKR1C4AKR1C3
SCHEMBL13486013 0.95 KDM4E (0.36) FLT3KDM4ECRHR1AKR1C4AKR1C3
SCHEMBL13486030 0.95 KDM4E (0.36) FLT3KDM4ECRHR1AKR1C4AKR1C3
SCHEMBL13486073 0.94 L3MBTL1 (0.35) FLT3KDM4ECRHR1AKR1C4AKR1C3
SCHEMBL13486029 0.94 L3MBTL1 (0.35) FLT3KDM4ECRHR1AKR1C4AKR1C3
SCHEMBL13485827 0.94 KDM4E (0.35) FLT3KDM4ECRHR1AKR1C4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394511-B2 Compound for forming organic film, and organic light emitting device and flat panel display device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2013-03-12 — — US disclosed
US-8394511-B2 Compound for forming organic film, and organic light emitting device and flat panel display device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2013-03-12 — — US disclosed
EP-2093271-A1 Compound for forming organic film, and organic light emitting device and flat panel display device including the same Samsung Mobile Display Co., Ltd. (KR) 2009-08-26 — — EP disclosed
US-20090200928-A1 COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2009-08-13 — — US disclosed
US-20090200928-A1 COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2009-08-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090200928-A1 COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME SLCO4C1, PORCN, SLC7A5 FLT3 4436/4885KDM4E 2323/4885KMT2A 2667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback